Fig. 5From: Identifying biomarkers of breast cancer micrometastatic disease in bone marrow using a patient-derived xenograft mouse modelPrincipal component (PC) analysis (PCA) of 16 bone marrow (BM) samples from patients with breast cancer (12 without distant relapse and 4 with distant relapse) and 6 healthy female control BM samples, based upon a 420-gene signature identified from Washington University Human in Mouse (WHIM17) BM samples. BRCA breast cancerBack to article page